In the Research Article, “Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy,” Tsolere Arakelian was added to the author list for her assistance and support in the acquisition, analysis, and interpretation of data.
The HTML and PDF versions of the paper were corrected.
